Enzo Biochem
ENZ
$1.37
Share price
0.00%
Change (1 day)
-45.42%
Change (1 year)
Categories
Revenue for Enzo Biochem (ENZ)
Revenue in 2023 (TTM): $71 M
According to Enzo Biochem's latest financial reports the company's current revenue (TTM) is $71 M. In 2022 the company made a revenue of $98.82 M a decrease over the years 2021 revenue that were of $0.11 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Enzo Biochem from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $71 M | -28.15% |
| 2022 | $98.82 M | -14.5% |
| 2021 | $0.11 B | 36.85% |
| 2020 | $84.46 M | 5.43% |
| 2019 | $80.11 M | -18.49% |
| 2018 | $98.29 M | -9.98% |
| 2017 | $0.10 B | 5.12% |
| 2016 | $0.10 B | 6.05% |
| 2015 | $97.95 M | 1.36% |
| 2014 | $96.63 M | 4.8% |
| 2013 | $92.21 M | -10.44% |
| 2012 | $0.10 B | 0.81% |
| 2011 | $0.10 B | 4.67% |
| 2010 | $97.57 M | 4.16% |
| 2009 | $93.67 M | 17.95% |
| 2008 | $79.41 M | 30.18% |
| 2007 | $61 M | 52.11% |
| 2006 | $40.1 M | -7.31% |
| 2005 | $43.26 M | 3.83% |
| 2004 | $41.67 M | -8.78% |
| 2003 | $45.68 M | -22.12% |
| 2002 | $58.66 M | -1.28% |
| 2001 | $59.41 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $9.48 B | 13,262.44% | 🇺🇸 USA |
 LabCorp LH | $14.09 B | 19,746.35% | 🇺🇸 USA |
 RadNet RDNT | $1.52 B | 2,052.24% | 🇺🇸 USA |
 Psychemedics PMD | $23.61 M | -66.74% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.55 B | 676.88% | 🇺🇸 USA |
 Qiagen QGEN | $1.97 B | 2,685.54% | 🇳🇱 Netherlands |